Tags Archives: VV ECMO

Perfusfind S.L.

Abstract Background Weaning from venovenous extracorporeal membrane oxygenation (VV-ECMO) is not well studied. VV-ECMO can be discontinued when patients tolerate non-injurious mechanical ventilation (MV) during a sweep gas off trial..

Perfusfind S.L.

Abstract Systemic hypertension (HTN) is a recognized complication of veno-venous (VV) extracorporeal membrane oxygenation (ECMO) in children. We sought to determine the prevalence and associated features of HTN in a..

Perfusfind S.L.

Abstract The use of venovenous extracorporeal membrane oxygenation (VV ECMO) among adults is rapidly increasing worldwide. By 2020, the Extracorporeal Life Support Organization (ELSO) Registry had recorded >24,000 cases of..

Perfusfind S.L.

This program details the RESP and PRESERVE scores for predicting survival with the use of V-V ECMO in the ARDS patient. The program also details a single practice-multi, center program's..

Perfusfind S.L.

Abstract Background We sought to clarify the benefit of cytokine adsorption in patients with COVID-19 supported with venovenous extracorporeal membrane oxygenation (ECMO). Methods We did a single-centre, open-label, randomised, controlled..

Perfusfind S.L.

Abstract Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) has become an integral part in the rescue therapy of severe acute respiratory distress syndrome (ARDS) and may be lifesaving in patients with..

Perfusfind S.L.

“Extracorporeal Oxygenation and Coronavirus Disease 2019 Epidemic: Is the Membrane Fail-Safe to Cross Contamination?” - Tammy Sparacino Journal Club. Surfactant - John Ingram Knowledge Nuggets. Venovenous extracorporeal membrane oxygenation (ECMO)..

Perfusfind S.L.

Abstract CORONAVIRUS DISEASE 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a complex multisystem disorder primarily characterized by pulmonary involvement.  Although lung injury leading to..

Perfusfind S.L.

Abstract Patients who receive venovenous extracorporeal membrane oxygenation (VV ECMO) support upon failure of invasive mechanical ventilation (IMV) and other adjuncts, including low tidal volume, prone positioning, adjusted positive end-expiratory pressure, and..

Perfusfind S.L.

Abstract Objective Failure of membrane oxygenator (MO) function of venovenous extracorporeal membrane oxygenators (VV ECMO) remains problematic. The development of device-induced coagulation disorder (COD) or worsened gas transfer (WGT) necessitates..

Perfusfind S.L.

Joe Basha, CCP lectures on Extracorporeal Membrane Oxygenation (ECMO) safety and discussions on ECMO circuit design to minimize risks.   

Perfusfind S.L.

ECMO: Measurement Of Adequacy, Cannulation, North/South Complication, Anticoagulation And Weaning, And What Patients Can Be Woken Up And Extubated On VV ECMO?   

Perfusfind S.L.

Tammy Sparacino Journal Club: Heparin - free ( VV ECMO) Veno - Venous Extracorporeal Membrane Oxygenation in a multiple trauma patient: A case report.  Anticogulation free ECMO: Is this safe? ..

Perfusfind S.L.

Excellent presentation and discussion of recirculation in you V-V ECMO circuit. Single or double cannulation techniques and learn how increased flows and volume changes can affect the amount of recirculation..

Perfusfind S.L.

Tammy Sparacino Journal Club - John Ingram Knowledge Nuggets  Tammy Sparacino Journal Club: Heparin - free ( VV ECMO) Veno - Venous Extracorporeal Membrane Oxygenation in a multiple trauma patient:..

Perfusfind S.L.

Abstract A previously healthy, middle-aged patient presented with rapidly increasing shortness of breath despite empirical antibiotic treatment for presumed pneumonia. A computed tomographic image of the chest was notable for..

Perfusfind S.L.

Abstract Adult patients with uncorrected congenital heart diseases and chronic intracardiac shunt may develop Eisenmenger syndrome (ES) due to progressive increase of pulmonary vascular resistance, with significant morbidity and mortality...

Perfusfind S.L.

Abstract Objective: The COVID-19 pandemic requires thinking about alternatives to establish ECMO when often-limited hardware resources are exhausted. Heart-lung-machines may potentially be used for ECMO but contain roller pumps as..

Perfusfind S.L.

Abstract Patients supported with venovenous extracorporeal membrane oxygenation are at risk for intra-abdominal hypertension and abdominal compartment syndrome. Flow through the return cannula may be compromised in these patients, resulting..

Perfusfind S.L.

Abstract To the Editor: Tay et al provide an excellent overview on the practical management of venovenous extracorporeal membrane oxygenation (VV-ECMO). The physiologic basis for the proposed algorithms should be discussed..

Perfusfind S.L.

Abstract A 53-year-old male was submitted to veno-venous extracorporeal membrane oxygenation (ECMO) due to coronavirus disease 2019 (COVID-19) pneumonia for 84 days, without relevant complications related to the circuit itself until..

Perfusfind S.L.

Abstract This chapter explores the best practices of mechanical ventilation during extracorporeal membrane oxygenation (ECMO) through a detailed discussion of the physiologic theory and clinical evidence. Future areas of study..

Perfusfind S.L.

V-A ECMO V-V ECMO Variation in V-V ECMO cannulae sites Central cannulation for V-A ECMO  

Perfusfind S.L.

Abstract Traditional venovenous (VV) extracorporeal membrane oxygenation (ECMO) for respiratory failure requires deep sedation and immobilization of patients, both of which carry high morbidity and mortality rates. Technological innovation has..

Perfusfind S.L.

Abstract Objectives:  Extracorporeal membrane oxygenation is a life-sustaining therapy for severe respiratory failure. Extracorporeal membrane oxygenation circuits require systemic anticoagulation that creates a delicate balance between circuit-related thrombosis and bleeding-related..

Perfusfind S.L.

Abstract Introduction: Veno-venous extracorporeal membrane oxygenation (vvECMO) used for respiratory support is associated with clinical bleeding in at least one third of patients. Mechanisms promoting bleeding, like acquired von Willebrand..

Perfusfind S.L.

Abstract Background Lactate has been recognised as a  in several critical conditions. Veno-Venous  (VV-ECMO) is a well-established therapy in patients with  Syndrome (ARDS) unresponsive to conventional therapy and  pre ECMO initiation has been recently..

Perfusfind S.L.

Abstract Peripartum cardiomyopathy (PPCM) is a rare disorder of unknown etiology and pathogenesis. The most important tool for diagnostic confirmation is transthoracic echocardiography. The recommended management of PPCM in pregnancy..

Perfusfind S.L.

Abstract Cardiopulmonary AG, Rastatt, Germany) can be effective in patients requiring venovenous extracorporeal membrane oxygenation (VV-ECMO) for adult respiratory distress syndrome (ARDS). Proper placement of the cannula is important in..

Perfusfind S.L.

Abstract Patients with coronavirus disease 2019 (COVID-19) are prone to pulmonary artery hypertension (PAH) and right ventricular pressure overload due to severe bilateral infiltrates, high ventilation pressures, persistent hypoxemia, pulmonary..